Evidence has demonstrated that we can do a great deaI to prevent and minimalize the occurence of CTE (Concussion Tramatic Encephalophy), damage due to repetitive head injuries. Which of the answers below are true:

Pilonidal dimpling with the presence of an abnormal tuft of hair in or near the dimple

Explanation:

Spina bifida is a congenital condition where there is incomplete closing of the backbone and membranes around the spinal cord during early development in the womb. Pilonidal dimpling with the presence of an abnormal tuft of hair in or near the dimple is a specific sign of spina bifida. This condition is called "sacral dimple," and it can indicate an underlying issue with the spinal cord and nerves. An abnormal tuft of hair in or near the dimple suggests a neural tube defect, which is characteristic of spina bifida.

Why the other choices are incorrect:

A. complete paralysis:

Complete paralysis is a severe neurological symptom but it is not specific to spina bifida. It can occur due to various other conditions as well, such as spinal cord injuries, infections, and neurological disorders. It's not a characteristic sign of spina bifida.

B. Petechiae:

Petechiae are small, red or purple spots on the skin that are caused by bleeding under the skin. They are usually associated with bleeding disorders, infections, or other medical conditions. Petechiae are not a characteristic sign of spina bifida.

C. Abnormal Vital Signs:

While spina bifida can potentially lead to neurological complications that might influence vital signs, the presence of abnormal vital signs is a non-specific symptom. Abnormal vital signs could be caused by a wide range of medical conditions, and they are not directly indicative of spina bifida.

Digoxin is a medication commonly used to treat certain heart conditions, including some congenital heart defects. It's important to monitor the heart rate and other signs of toxicity when administering digoxin, especially in pediatric patients. Let's break down the information given:

The pediatric maintenance dose of digoxin is 5 mcg/kg daily.

The child weighs 55 pounds (approximately 25 kg).

Given these values, the total daily dose for this child would be:

Total daily dose = 5 mcg/kg × 25 kg = 125 mcg

This total daily dose is usually given as a single dose. However, the child's heart rate is noted to be only 50 beats per minute (bpm). A heart rate of 50 bpm in a child could potentially indicate bradycardia (slow heart rate), which can be a sign of digoxin toxicity. Bradycardia is a known adverse effect of digoxin, and it's important to assess for other signs of toxicity as well, such as nausea, vomiting, and changes in color vision.

In this case, it would be prudent to withhold the digoxin and assess the child further for signs of toxicity or bradycardia. The dose should not be administered until the healthcare provider is consulted and appropriate action is determined.

So, the correct answer is indeed NO. Administering the digoxin without considering the slow heart rate and the potential for toxicity could be unsafe for the child.